OnKure Therapeutics, Inc.
USD4.20
-0.02 (-0.47%)
CEO
Nicholas A. Saccomano
IPO Date
2021-04-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.11
Prev. Close
$4.22
Day Low
$4.04
Day High
$4.40
52W Low
$1.91
52W High
$5.38
Market Cap
$0.06B
Volume
0.33M
| 5,640,222 |
| $0.00 |
| 3 Apr 2026 | Saccomano Nicholas A | director, officer: President and CEO | A-Award | Acquired | 330,000 | $4.07 |
| 3 Apr 2026 | Leverone Jason A. | Chief Financial Officer | A-Award | Acquired | 110,000 | $4.07 |
| 3 Apr 2026 | Hartley Dylan | Chief Scientific Officer | A-Award | Acquired | 110,000 | $4.07 |
| 3 Apr 2026 | Agresta Samuel | Chief Medical Officer | A-Award | Acquired | 110,000 | $4.07 |
| 1 Apr 2026 | Ratcliffe Liam | director | A-Award | Acquired | 15,300 | $4.14 |
| 1 Apr 2026 | Ratcliffe Liam | — | Disposed | 0 | $0.00 |
| 24 Mar 2026 | Saccomano Nicholas A | director, officer: President and CEO | S-Sale | Disposed | 86 | $4.16 |
| 24 Mar 2026 | Leverone Jason A. | Chief Financial Officer | S-Sale | Disposed | 301 | $4.16 |